Skip to Content

Vaccines, Volume 12, Issue 3

2024 March - 124 articles

Cover Story: Nucleic acid vaccines (i.e., viral vectors, DNA vaccines and mRNA vaccines) provide multiple advantages over other vaccine platforms like subunit proteins or whole-pathogen vaccines. As demonstrated during the SARS-CoV-2 pandemics, their versatility and unique protocols allowed for fast adaptation to novel immunogens. These advantages can benefit the HIV vaccine field that is in dire need of delivery platforms that can be rapidly adapted to a highly mutating virus, while being highly immunogenic. Hence, combining the most relevant HIV immunogens as soluble proteins or those displayed on multivalent platforms with DNA and mRNA systems can pave the way towards the development of HIV vaccines. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (124)

  • Article
  • Open Access
4 Citations
4,700 Views
17 Pages

Analysis of Attitudes and Practices towards the Influenza Vaccine in High-Risk Adults in Poland

  • Dorota Kopciuch,
  • Karolina Hoffmann,
  • Krzysztof Kus,
  • Agnieszka Koligat-Seitz,
  • Piotr Ratajczak,
  • Elżbieta Nowakowska and
  • Anna Paczkowska

21 March 2024

This study aimed to understand Poles’ attitudes and beliefs towards influenza vaccinations in the flu season of 2022–2023, especially among individuals at risk of flu complications. The cross-sectional survey-based study was carried out o...

  • Article
  • Open Access
2 Citations
3,294 Views
17 Pages

Oncolytic Adenovirus Armed with a Novel Agonist of the CD137 Immune Checkpoint Stimulator Suppresses Tumor Growth

  • Martin R. Ramos-Gonzalez,
  • Mohammad Tarique,
  • Lalit Batra,
  • Feyza Arguc,
  • Rodolfo Garza-Morales,
  • Haval Shirwan,
  • Esma S. Yolcu and
  • Jorge G. Gomez-Gutierrez

21 March 2024

Natural 4-1BBL (CD137L) is a cell membrane-bound protein critical to the expansion, effector function, and survival of CD8+ T cells. We reported the generation of an active soluble oligomeric construct, SA-4-1BBL, with demonstrated immunoprevention a...

  • Article
  • Open Access
8 Citations
4,380 Views
20 Pages

Microfluidic Synthesis of Scalable Layer-by-Layer Multiple Antigen Nano-Delivery Platform for SARS-CoV-2 Vaccines

  • Yang Xu,
  • Kazuya Masuda,
  • Christine Groso,
  • Rick Hassan,
  • Ziyou Zhou,
  • Kelsey Broderick,
  • Moriya Tsuji and
  • Christopher Tison

21 March 2024

The COVID-19 outbreak was a global pandemic with wide-ranging healthcare implications. Although several mRNA-based vaccines delivered using lipid nanoparticles (LNP) have been approved and demonstrated efficacy at reducing the severity and spread of...

  • Communication
  • Open Access
6 Citations
2,840 Views
9 Pages

National Immunization Program Decision Making Using the CAPACITI Decision-Support Tool: User Feedback from Indonesia and Ethiopia

  • Maarten Jansen,
  • Dijana Spasenoska,
  • Mardiati Nadjib,
  • Desalegn Ararso,
  • Raymond Hutubessy,
  • Anna-Lea Kahn and
  • Philipp Lambach

20 March 2024

To ensure that limited domestic resources are invested in the most effective interventions, immunization programs in low- and middle-income countries (LMICs) must prioritize a growing number of new vaccines while considering opportunities to optimize...

  • Article
  • Open Access
14 Citations
2,412 Views
13 Pages

20 March 2024

Background: This cross-sectional survey investigated the knowledge, attitudes, and coverage of recommended vaccinations among a random sample of patients with chronic medical conditions, at higher risk of vaccine-preventable diseases (VPDs), in Italy...

  • Article
  • Open Access
9 Citations
2,713 Views
11 Pages

Seroprevalence for Measles, Varicella, Mumps and Rubella in the Trainee Obstetric Population: A Survey in Southern Italy

  • Brunella Perfetto,
  • Giovanna Paduano,
  • Elena Grimaldi,
  • Vincenza Sansone,
  • Giovanna Donnarumma and
  • Gabriella Di Giuseppe

20 March 2024

Background: Despite the efforts of the World Health Organization, some childhood viral diseases, for which there is already an effective vaccine, have not yet been eradicated. Among these, we find varicella, mumps, measles, and rubella, which althoug...

  • Article
  • Open Access
2 Citations
3,796 Views
13 Pages

Baculovirus Vector-Based Varicella-Zoster Virus Vaccine as a Promising Alternative with Enhanced Safety and Therapeutic Functions

  • Chanyeong Lee,
  • Minjee Kim,
  • Jungmin Chun,
  • Sehyun Kim,
  • Doyoung Yoon,
  • Hyeondong Lee,
  • Heewon Bang,
  • Hee-Jung Lee,
  • Hosun Park and
  • Young Bong Kim

20 March 2024

Varicella-zoster virus (VZV) poses lifelong risks, causing varicella and herpes zoster (HZ, shingles). Currently, varicella and HZ vaccines are predominantly live attenuated vaccines or adjuvanted subunit vaccines utilizing VZV glycoprotein E (gE). H...

  • Article
  • Open Access
3 Citations
3,137 Views
10 Pages

The Role of Pharmacists in Counteracting Vaccine Hesitancy: Effectiveness of the 2019 Carnia Project in Improving Adherence to Influenza Vaccination among Target Population

  • Gloria Longobardi,
  • Laura Brunelli,
  • Benedetta Piciocchi,
  • Andrea Morsanutto,
  • Andrea Iob,
  • Flavio Schiava,
  • Claudio Luigi Pancino,
  • Luca Degrassi,
  • Giuseppe Tonutti and
  • Luca Arnoldo
  • + 1 author

20 March 2024

Vaccine hesitancy has been included among the top ten threats to global health by the World Health Organization. Pharmacists can play a pivotal role in removing the individual barrier to vaccination, because of the relationship of trust they have wit...

  • Article
  • Open Access
8 Citations
2,815 Views
10 Pages

20 March 2024

An mpox outbreak occurred suddenly and rapidly spread worldwide in 2022. Research has demonstrated a link between the sexual behavior of men who have sex with men (MSM) and the contraction of mpox. This study assessed the factors related to mpox-vacc...

  • Review
  • Open Access
12 Citations
4,761 Views
31 Pages

Towards a Safer Future: Enhancing Vaccine Development to Combat Animal Coronaviruses

  • Fusheng Si,
  • Ruisong Yu,
  • Shijuan Dong,
  • Bingqing Chen,
  • Chunhua Li and
  • Shuai Song

19 March 2024

Coronaviruses (CoVs) are a large class of positively stranded RNA viruses that pose a significant threat to public health, livestock farming, and wild animals. These viruses have the ability to cross species barriers and cause devastating epidemics....

  • Article
  • Open Access
1 Citations
2,265 Views
16 Pages

Risk Factors for COVID-19 and Respiratory Tract Infections during the Coronavirus Pandemic

  • Laurynas Mockeliunas,
  • Rob C. van Wijk,
  • Caryn M. Upton,
  • Jonathan Peter,
  • Andreas H. Diacon and
  • Ulrika S. H. Simonsson

19 March 2024

(1) Background: Some individuals are more susceptible to developing respiratory tract infections (RTIs) or coronavirus disease (COVID-19) than others. The aim of this work was to identify risk factors for symptomatic RTIs including COVID-19 and sympt...

  • Article
  • Open Access
3 Citations
4,031 Views
14 Pages

Low Measles Vaccination Coverage and Spatial Analysis of High Measles Vaccination Dropout in Ethiopia’s Underprivileged Areas

  • Fisseha Shiferie,
  • Samson Gebremedhin,
  • Gashaw Andargie,
  • Dawit A. Tsegaye,
  • Wondwossen A. Alemayehu and
  • Teferi Gedif Fenta

19 March 2024

(1) Background: Measles remains a major cause of disease and death worldwide, especially in the World Health Organization African Region. This study aimed to estimate the coverage of measles vaccinations and map the spatial distribution of measles va...

  • Article
  • Open Access
3,488 Views
12 Pages

SARS-CoV-2 Symptoms during the Omicron Surge Differ between Boosted and Vaccinated Non-Boosted Persons

  • Marisa A. Montecalvo,
  • Paul Visintainer,
  • Elizabeth Drugge,
  • Katherine Kowalski,
  • Rosemarie Raffa,
  • Donna McKenna,
  • Christine Moronta and
  • Gary P. Wormser

19 March 2024

Purpose: To determine the impact of booster COVID-19 vaccination on SARS-CoV-2 symptoms. Background: The Omicron surge of infections provided an opportunity to evaluate symptoms in relation to booster receipt. Methods: At a US medical college, the nu...

  • Article
  • Open Access
4 Citations
3,504 Views
13 Pages

Comparative Analysis of SARS-CoV-2 Antibody Responses across Global and Lesser-Studied Vaccines

  • José Victor Zambrana,
  • Carlos Saenz,
  • Hannah E. Maier,
  • Mayling Brenes,
  • Andrea Nuñez,
  • Anita Matamoros,
  • Mabel Hernández,
  • Keyla Dumas,
  • Cristhian Toledo and
  • Angel Balmaseda
  • + 2 authors

19 March 2024

Few data are available on antibody response for some SARS-CoV-2 vaccines, and there is a lack of ability to compare vaccine responses in the same population. This cross-sectional study conducted in Nicaragua examines the SARS-CoV-2 antibody responses...

  • Article
  • Open Access
2 Citations
3,205 Views
17 Pages

Development of a Potency Assay for Nous-209, a Multivalent Neoantigens-Based Genetic Cancer Vaccine

  • Rosa Bartolomeo,
  • Fulvia Troise,
  • Simona Allocca,
  • Giulia Sdruscia,
  • Rosa Vitale,
  • Veronica Bignone,
  • Anna Maria Petrone,
  • Giuseppina Romano,
  • Anna Morena D’Alise and
  • Gabriella Cotugno
  • + 8 authors

19 March 2024

Quality control testing of vaccines, including potency assessment, is critical to ensure equivalence of clinical lots. We developed a potency assay to support the clinical advancement of Nous-209, a cancer vaccine based on heterologous prime/boost ad...

  • Article
  • Open Access
4 Citations
3,129 Views
24 Pages

Humoral and Cellular Immune Responses Induced by Bivalent DNA Vaccines Expressing Fusion Capsid Proteins of Porcine Circovirus Genotypes 2a and 2b

  • Sochanwattey Meas,
  • Khuanjit Chaimongkolnukul,
  • Jaraspim Narkpuk,
  • Phenjun Mekvichitsaeng,
  • Kanokwan Poomputsa,
  • Nanchaya Wanasen and
  • Yaowaluck Maprang Roshorm

18 March 2024

Porcine circovirus type 2 (PCV2) is the main causative agent of porcine circovirus-associated disease (PCVAD) that profoundly impacts the swine industry worldwide. While most of the commercial PCV vaccines are developed based on PCV genotype 2a (PCV2...

  • Article
  • Open Access
3 Citations
2,276 Views
14 Pages

Determinants of an HIV Preventive Vaccine among a Highly Vulnerable Population: African American Men Who Have Sex with Men

  • Mia Ann Xu,
  • Jasmin Choi,
  • Joshua G. Rosenberger,
  • Rick S. Zimmerman and
  • Ralph DiClemente

18 March 2024

African American men who have sex with men (MSM) are disproportionately impacted by HIV and may benefit from the development of an HIV vaccine. African American MSM are adversely affected by discrimination as a function of both their race and sexual...

  • Article
  • Open Access
2,671 Views
14 Pages

Exploratory Study of the Phase IV Immunization Schedule of Quadrivalent Influenza Split-Virion Vaccine in Children Aged 3–8 Years

  • Xiaoyu Li,
  • Zengqiang Kou,
  • Ti Liu,
  • Wenjue An,
  • Wenqi An,
  • Wei Zhang,
  • Ke Zhang,
  • Jie Dong,
  • Jiangxuan Yu and
  • Chenyan Zhao
  • + 1 author

18 March 2024

This study explored the optimum immunization schedule for the quadrivalent influenza split-virion vaccine containing influenza A strains (H1N1 and H3N2) and B lineage strains (Yamagata and Victoria) in children aged 3–8 years. The 652 participa...

  • Article
  • Open Access
1 Citations
3,026 Views
24 Pages

18 March 2024

The Marburg virus (MARV), the virus responsible for Marburg hemorrhagic fever (MHF), is considered a top-priority pathogen for vaccine development. Recent outbreaks in Equatorial Africa have highlighted the urgency of MARV because of its high fatalit...

  • Article
  • Open Access
2,927 Views
19 Pages

Differential Immune Response Patterns Induced by Anionic and Cationic Lipid Adjuvants in Intranasal Anti-Influenza Immunization

  • Anirban Sengupta,
  • Noha Al-Otaibi,
  • Claudia Devito,
  • Francisca Lottersberger and
  • Jorma Hinkula

18 March 2024

Currently, vaccine development against different respiratory diseases is at its peak. It is of utmost importance to find suitajble adjuvants that can increase the potency of the vaccine candidates. This study aimed to determine the systemic and splen...

  • Article
  • Open Access
1 Citations
2,531 Views
15 Pages

Factors Affecting the Implementation and Acceptance of the Cocoon Strategy in the NICU in a Tertiary Center in Türkiye

  • Şeyma Karatekin,
  • Selda Hançerli Törün,
  • Ebru Şenol,
  • Salih Çağrı Çakır and
  • Gülbin Gökçay

18 March 2024

Pertussis is an important cause of mortality and morbidity in infancy. It is recommended that close contacts of the baby be vaccinated with Tdap, and this practice is called the cocoon strategy. This study aimed to investigate the applicability of th...

  • Review
  • Open Access
35 Citations
29,727 Views
26 Pages

Self-Amplifying RNA: A Second Revolution of mRNA Vaccines against COVID-19

  • Noelia Silva-Pilipich,
  • Uxue Beloki,
  • Laura Salaberry and
  • Cristian Smerdou

17 March 2024

SARS-CoV-2 virus, the causative agent of COVID-19, has produced the largest pandemic in the 21st century, becoming a very serious health problem worldwide. To prevent COVID-19 disease and infection, a large number of vaccines have been developed and...

  • Article
  • Open Access
7 Citations
2,528 Views
12 Pages

17 March 2024

Vaccine hesitancy poses a significant threat to the health of individuals across all age groups, which has been exacerbated by the COVID-19 pandemic. In this cross-sectional study, an extension of the Theory of Planned Behavior (TPB) was applied to i...

  • Article
  • Open Access
4 Citations
3,177 Views
20 Pages

Unveiling a Shield of Hope: A Novel Multiepitope-Based Immunogen for Cross-Serotype Cellular Defense against Dengue Virus

  • Nilanshu Manocha,
  • Daphné Laubreton,
  • Xavier Robert,
  • Jacqueline Marvel,
  • Virginie Gueguen-Chaignon,
  • Patrice Gouet,
  • Prashant Kumar and
  • Madhu Khanna

16 March 2024

Dengue virus (DENV) infection continues to be a public health challenge, lacking a specific cure. Vaccination remains the primary strategy against dengue; however, existing live-attenuated vaccines display variable efficacy across four serotypes, inf...

  • Article
  • Open Access
5 Citations
3,027 Views
11 Pages

The Effectiveness of the Third Dose of COVID-19 Vaccine: When Should It Be Performed?

  • Giacomo Biganzoli,
  • Marco Mendola,
  • Pier Mario Perrone,
  • Laura Maria Antonangeli,
  • Anna Beatrice Elena Longo,
  • Paolo Carrer,
  • Claudio Colosio,
  • Dario Consonni,
  • Giuseppe Marano and
  • Silvana Castaldi
  • + 2 authors

16 March 2024

Background: COVID-19 vaccination is the most significant step toward the long-term mitigation of SARS-CoV-2-related complication, avoiding disease and death and decreasing virus spread. This study aimed to evaluate, in a real-world setting, booster d...

  • Communication
  • Open Access
6 Citations
3,918 Views
7 Pages

Estimating the Impact of Vaccination Campaigns on Measles Transmission in Somalia

  • Niket Thakkar,
  • Ali Haji Adam Abubakar,
  • Mukhtar Shube,
  • Mustafe Awil Jama,
  • Mohamed Derow,
  • Philipp Lambach,
  • Hossam Ashmony,
  • Muhammad Farid,
  • So Yoon Sim and
  • Sk Md Mamunur Rahman Malik
  • + 6 authors

16 March 2024

Somalia is a complex and fragile setting with a demonstrated potential for disruptive, high-burden measles outbreaks. In response, since 2018, Somalian authorities have partnered with UNICEF and the WHO to implement measles vaccination campaigns acro...

  • Review
  • Open Access
8 Citations
6,050 Views
42 Pages

15 March 2024

Burkholderia are a group of Gram-negative bacteria that can cause a variety of diseases in at-risk populations. B. pseudomallei and B. mallei, the etiological agents of melioidosis and glanders, respectively, are the two clinically relevant members o...

  • Article
  • Open Access
1 Citations
3,788 Views
14 Pages

Pilot Study on Evaluating the Impact of Tetanus, Diphtheria, and Pertussis (Tdap), Influenza, and COVID-19 Vaccinations on Antibody Responses in Pregnant Women

  • Wei-Chun Chen,
  • Shu-Yu Hu,
  • Chao-Min Cheng,
  • Ching-Fen Shen,
  • Hui-Yu Chuang,
  • Chin-Ru Ker,
  • Der-Ji Sun and
  • Ching-Ju Shen

15 March 2024

This study assessed IgG levels to influenza/pertussis and neutralizing antibody (Nab) responses of COVID-19 vaccines in blood of pregnant women following immunization with pertussis (Tdap), influenza, and COVID-19 vaccines. We prospectively collected...

  • Article
  • Open Access
2 Citations
2,762 Views
13 Pages

15 March 2024

Although immunization is one of the most successful and cost-effective interventions that prevents millions of infant and child deaths yearly, it has failed to achieve its intended goals in some low-income countries. Yemen is currently experiencing t...

  • Article
  • Open Access
2 Citations
2,850 Views
15 Pages

Immunization with centrin-Deficient Leishmania braziliensis Does Not Protect against Homologous Challenge

  • Francys Avendaño-Rangel,
  • Gabriela Agra-Duarte,
  • Pedro B. Borba,
  • Valdomiro Moitinho,
  • Leslye T. Avila,
  • Larissa O. da Silva,
  • Sayonara M. Viana,
  • Rohit Sharma,
  • Sreenivas Gannavaram and
  • Camila I. de Oliveira
  • + 1 author

15 March 2024

Immunization with various Leishmania species lacking centrin induces robust immunity against a homologous and heterologous virulent challenge, making centrin mutants a putative candidate for a leishmaniasis vaccine. Centrin is a calcium-binding cytos...

  • Article
  • Open Access
5 Citations
3,434 Views
20 Pages

Comparative Transcriptome Analysis of Babesia bigemina Attenuated Vaccine and Virulent Strains of Mexican Origin

  • Rebeca M. Santamaria,
  • Karel Estrada,
  • María E. López,
  • Edith Rojas,
  • Grecia Martínez,
  • Yazmín Alcalá,
  • Carmen Rojas,
  • Jesús Antonio Álvarez,
  • José J. Lira and
  • Julio V. Figueroa
  • + 2 authors

15 March 2024

Bovine babesiosis, caused by the protozoan Babesia bigemina, is one of the most important hemoparasite diseases of cattle in Mexico and the world. An attenuated B. bigemina strain maintained under in vitro culture conditions has been used as a live a...

  • Article
  • Open Access
5 Citations
2,607 Views
18 Pages

SARS-CoV-2 Neutralization Capacity in Hemodialysis Patients with and without a Fifth Vaccination with the Updated Comirnaty Original/Omicron BA.4-5 Vaccine

  • Bo-Hung Liao,
  • Louise Platen,
  • Myriam Grommes,
  • Cho-Chin Cheng,
  • Christopher Holzmann-Littig,
  • Catharina Christa,
  • Bernhard Haller,
  • Verena Kappler,
  • Romina Bester and
  • Matthias Christoph Braunisch
  • + 9 authors

15 March 2024

Background: Hemodialysis patients have reduced serologic immunity after SARS-CoV-2 vaccination compared to the general population and an increased risk of morbidity and mortality when exposed to SARS-CoV-2. Methods: Sixty-six hemodialysis patients im...

  • Article
  • Open Access
5 Citations
3,826 Views
12 Pages

Simultaneous Detection of Antigen and Antibodies of African Swine Fever in a Novel Combo Lateral Flow Assay

  • Cristina Aira,
  • Gabriela González-García,
  • Juan Martínez-Cano,
  • Nuria de la Roja,
  • Monica Giammarioli,
  • Francesco Feliziani,
  • Žanete Šteingolde,
  • Jurate Buitkuviene,
  • Petr Václavek and
  • Alba Fresco-Taboada
  • + 5 authors

14 March 2024

African swine fever (ASF) is a contagious disease of wild boar and domestic pigs notifiable to the World Organisation for Animal Health due to its high socio-economic impact. ASF is caused by the complex ASF virus (ASFV), and it can present different...

  • Systematic Review
  • Open Access
6 Citations
10,803 Views
18 Pages

Parsonage–Turner Syndrome following COVID-19 Vaccination: A Systematic Review

  • Elena Cecilia Rosca,
  • Almonzer Al-Qiami,
  • Amalia Cornea and
  • Mihaela Simu

14 March 2024

Background: Parsonage–Turner syndrome (PTS) is an inflammatory condition of the brachial plexus, with more than half of patients presenting a trigger, such as infection or vaccination. Our objective was to synthesize the clinical and paraclinic...

  • Article
  • Open Access
11 Citations
4,436 Views
10 Pages

14 March 2024

The current influenza season started in Italy in October 2023, approaching the epidemic peak in late December (52nd week of the year). We aimed to explore the mid-term virologic surveillance data of the 2023/2024 influenza season (from 16 October 202...

  • Article
  • Open Access
3 Citations
3,125 Views
24 Pages

Application of Recombinant Lactic Acid Bacteria (LAB) Live Vector Oral Vaccine in the Prevention of F4+ Enterotoxigenic Escherichia coli

  • Jiangxu Yu,
  • Jiyang Fu,
  • Hongshuo Liu,
  • Chao Kang,
  • Zesong Wang,
  • Yancheng Jin,
  • Shuxuan Wu,
  • Tianzhi Li,
  • Ruicheng Yang and
  • Xiangru Wang
  • + 2 authors

14 March 2024

Enterotoxigenic Escherichia coli (ETEC) causes severe diarrhea in piglets. The current primary approach for ETEC prevention and control relies on antibiotics, as few effective vaccines are available. Consequently, an urgent clinical demand exists for...

  • Article
  • Open Access
2,401 Views
13 Pages

14 March 2024

Immunization against influenza through vaccination is the most effective method with which to prevent infection. To assess protection after immunization, analysing humoral response with a hemagglutinin inhibition assay is the gold standard, but cell-...

  • Article
  • Open Access
4 Citations
4,285 Views
19 Pages

Evaluation of a Combined Live Attenuated Vaccine against Lumpy Skin Disease, Contagious Bovine Pleuropneumonia and Rift Valley Fever

  • Zohra Bamouh,
  • Amal Elarkam,
  • Soufiane Elmejdoub,
  • Jihane Hamdi,
  • Zineb Boumart,
  • Greg Smith,
  • Matthew Suderman,
  • Mahder Teffera,
  • Hezron Wesonga and
  • Mehdi Elharrak
  • + 4 authors

13 March 2024

The use of effective vaccines is among the most important strategies for the prevention and progressive control of transboundary infectious animal diseases. However, the use of vaccine is often impeded by the cost, a lack of cold chains and other fac...

  • Article
  • Open Access
6 Citations
2,932 Views
13 Pages

13 March 2024

The immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) becomes increasingly complex as individuals receive different combinations of vaccine doses and encounter breakthrough infections. Our study focused on the immunogeni...

  • Article
  • Open Access
6 Citations
3,258 Views
13 Pages

Influenza a Neuraminidase-Based Bivalent mRNA Vaccine Induces Th1-Type Immune Response and Provides Protective Effects in Mice

  • Mingyang Li,
  • Mengyuan Liu,
  • Shaohui Song,
  • Ruirui Zhao,
  • Yun Xie,
  • Jing Liu,
  • Lilan Xu,
  • Xuefeng Ma,
  • Mingyu Song and
  • Guoyang Liao
  • + 1 author

13 March 2024

Vaccines are one of the most effective means of preventing influenza A, typically containing the hemagglutinin (HA) of the influenza A virus. However, antigenic drift and shift of the influenza A virus can lead to instability in vaccine efficacy. Com...

  • Article
  • Open Access
2,022 Views
11 Pages

Long-Term Immunological Alertness and Response to COVID-19 Vaccination—Conditions for Prevention in Early Palliative Oncological Care Patients

  • Peter Priester,
  • Miroslav Fajfr,
  • Veronika Molnarova,
  • Radek Sleha,
  • Sylva Janovska,
  • Pavel Bostik and
  • Stanislav Filip

13 March 2024

Aside from the general population, the COVID-19 pandemic has also affected a group of patients in palliative oncology care. In this study, long-term immune responses against SARS-CoV-2 after vaccination were monitored in a cohort of patients in palli...

  • Review
  • Open Access
2 Citations
5,392 Views
23 Pages

Nucleic Acid Vaccines Encoding Proteins and Virus-like Particles for HIV Prevention

  • Ferran Tarrés-Freixas,
  • Bonaventura Clotet,
  • Jorge Carrillo and
  • Julià Blanco

12 March 2024

The development of HIV prophylactic vaccines is facing an impasse, since all phase IIb/III clinical trials were halted in 2023 without demonstrating efficacy. Thus, the field is in need of developing novel immunogens and vaccination strategies that i...

  • Article
  • Open Access
7 Citations
2,699 Views
18 Pages

Influenza Vaccine Uptake in Italy—The 2022–2023 Seasonal Influenza Vaccination Campaign in Italy: An Update from the OBVIOUS Project

  • Angelo Capodici,
  • Aurelia Salussolia,
  • Giusy La Fauci,
  • Zeno Di Valerio,
  • Marco Montalti,
  • Anna Odone,
  • Claudio Costantino,
  • Heidi J. Larson,
  • Julie Leask and
  • on behalf of the OBVIOUS Board
  • + 3 authors

12 March 2024

Influenza is a significant public health concern, with Italy being profoundly impacted annually. Despite extensive vaccination campaigns and cooperative initiatives between the Public Health Departments of Local Healthcare Authorities and family phys...

  • Article
  • Open Access
3 Citations
2,370 Views
14 Pages

Long-Term Observation of SARS-CoV-2 Vaccination Response upon High Efficacy Treatment in Multiple Sclerosis—A Real-World Scenario

  • Muriel Schraad,
  • Stefan Runkel,
  • Walter Hitzler,
  • Maria Protopapa,
  • Stefan Bittner,
  • Timo Uphaus and
  • Frauke Zipp

12 March 2024

Immunomodulatory and immunosuppressive therapy is needed in people with a chronic neuroinflammatory disease of the central nervous system such as multiple sclerosis (MS). Therefore, MS requires monitoring for and preventing against infectious disease...

  • Article
  • Open Access
2 Citations
3,347 Views
19 Pages

Evaluation of Two Vaccines against Foot-and-Mouth Disease Used in Transcaucasian Countries by Small-Scale Immunogenicity Studies Conducted in Georgia, Azerbaijan and Armenia

  • Efrem Alessandro Foglia,
  • Tengiz Chaligava,
  • Tamilla Aliyeva,
  • Satenik Kharatyan,
  • Vito Tranquillo,
  • Carsten Pötzsch,
  • Cornelis van Maanen,
  • Fabrizio Rosso,
  • Santina Grazioli and
  • Emiliana Brocchi

12 March 2024

In countries endemic for foot-and-mouth disease (FMD), routine or emergency vaccinations are strategic tools to control the infection. According to the WOAH/FAO guidelines, a prior estimation of vaccine effectiveness is recommendable to optimize cont...

  • Article
  • Open Access
11 Citations
3,891 Views
17 Pages

Design and Preclinical Evaluation of a Nanoparticle Vaccine against Respiratory Syncytial Virus Based on the Attachment Protein G

  • Richard Voorzaat,
  • Freek Cox,
  • Daan van Overveld,
  • Lam Le,
  • Lisanne Tettero,
  • Joost Vaneman,
  • Mark J. G. Bakkers and
  • Johannes P. M. Langedijk

12 March 2024

Human respiratory syncytial virus (RSV) poses a significant human health threat, particularly to infants and the elderly. While efficacious vaccines based on the F protein have recently received market authorization, uncertainties remain regarding th...

  • Article
  • Open Access
4 Citations
4,681 Views
15 Pages

Factors Involved in the Immunological Protection against Rabies Virus in Dogs in Spain

  • María Dolores Manzano,
  • Javier Cereza,
  • Jesús García,
  • Luis Javier Yus,
  • Juan José Badiola,
  • Juan Emilio Echevarria and
  • Marta Monzón

11 March 2024

Rabies, a viral disease spread by infected animal bites that causes encephalitis in humans and other mammals, is a neglected infectious disease present on all continents except Antarctica. Spain has been free of terrestrial rabies since 1978. However...

  • Article
  • Open Access
6 Citations
4,649 Views
13 Pages

11 March 2024

This randomized, double-blind, placebo-controlled phase 1/2 trial aimed at evaluating the safety and immunogenicity of Ad5-nCoV via aerosolized or intramuscular or intramuscular–aerosolized routes in SARS-CoV-2-negative adults aged over 18 year...

of 3

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Vaccines - ISSN 2076-393X